{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:27:04Z","timestamp":1792650424052,"version":"4.5.0"},"reference-count":119,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["JCYJ20210324115611032"],"award-info":[{"award-number":["JCYJ20210324115611032"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010877","name":"Science, Technology and Innovation Commission of Shenzhen Municipality","doi-asserted-by":"publisher","award":["KQTD20200909113758004"],"award-info":[{"award-number":["KQTD20200909113758004"]}],"id":[{"id":"10.13039\/501100010877","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbiological Research"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.micres.2022.126993","type":"journal-article","created":{"date-parts":[[2022,2,16]],"date-time":"2022-02-16T11:28:48Z","timestamp":1645010928000},"page":"126993","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Application of pseudovirus system in the development of vaccine, antiviral-drugs, and neutralizing antibodies"],"prefix":"10.1016","volume":"258","author":[{"given":"Qi","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micres.2022.126993_bib1","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.3389\/fmicb.2020.02020","article-title":"Evaluation of neutralizing antibodies against highly pathogenic coronaviruses: a detailed protocol for a rapid evaluation of neutralizing antibodies using vesicular stomatitis virus pseudovirus-based assay","volume":"11","author":"Almahboub","year":"2020","journal-title":"Front. Microbiol."},{"issue":"1","key":"10.1016\/j.micres.2022.126993_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.antiviral.2008.02.001","article-title":"Characterization of a trypsin-dependent avian influenza H5N1-pseudotyped HIV vector system for high throughput screening of inhibitory molecules","volume":"79","author":"Ao","year":"2008","journal-title":"Antivir. Res."},{"key":"10.1016\/j.micres.2022.126993_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100306","article-title":"SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis","volume":"296","author":"Bayati","year":"2021","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.micres.2022.126993_bib4","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1128\/jvi.64.5.2337-2344.1990","article-title":"Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site","volume":"64","author":"Bosch","year":"1990","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.micres.2022.126993_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2020.05.025","article-title":"Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients\u2019 B cells","volume":"182","author":"Cao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.micres.2022.126993_bib6","article-title":"Identification of bis-benzylisoquinoline alkaloids as SARSCoV-2 entry inhibitors from a library of natural products","author":"Chang-Long He1","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7870","key":"10.1016\/j.micres.2022.126993_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41586-021-03720-y","article-title":"In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains","volume":"596","author":"Chen","year":"2021","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.micres.2022.126993_bib8","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.cell.2020.09.033","article-title":"SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2","volume":"183","author":"Clausen","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.micres.2022.126993_bib9","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2024671","article-title":"Evaluation of the mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates","author":"Corbett","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.micres.2022.126993_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/v12050513","article-title":"Protocol and reagents for pseudotyping lentiviral particles with SARS-CoV-2 spike protein for neutralization assays","volume":"12","author":"Crawford","year":"2020","journal-title":"Viruses"},{"issue":"6518","key":"10.1016\/j.micres.2022.126993_bib11","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1126\/science.abd3072","article-title":"Neuropilin-1 is a host factor for SARS-CoV-2 infection","volume":"370","author":"Daly","year":"2020","journal-title":"Science"},{"issue":"6538","key":"10.1016\/j.micres.2022.126993_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/science.abg3055","article-title":"Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England","volume":"372","author":"Davies","year":"2021","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.micres.2022.126993_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.04.025","article-title":"Transmission, infectivity, and neutralization of a spike L452R SARS-CoV-2 variant","volume":"184","author":"Deng","year":"2021","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.micres.2022.126993_bib14","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.chom.2020.06.020","article-title":"A replication-competent vesicular stomatitis virus for studies of SARS-CoV-2 spike-mediated cell entry and its inhibition","volume":"28","author":"Dieterle","year":"2020","journal-title":"Cell Host Microbe"},{"issue":"11","key":"10.1016\/j.micres.2022.126993_bib15","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","article-title":"A third-generation lentivirus vector with a conditional packaging system","volume":"72","author":"Dull","year":"1998","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.micres.2022.126993_bib16","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1128\/jvi.65.3.1202-1207.1991","article-title":"Pseudotype formation of murine leukemia virus with the G protein of vesicular stomatitis virus","volume":"65","author":"Emi","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.micres.2022.126993_bib17","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc9396","article-title":"An alphavirus-derived replicon RNA vaccine induces SARS-CoV-2 neutralizing antibody and T cell responses in mice and nonhuman primates","author":"Erasmus","year":"2020","journal-title":"Sci. Transl. Med."},{"issue":"9","key":"10.1016\/j.micres.2022.126993_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/v10090448","article-title":"A human DPP4-knockin mouse\u2019s susceptibility to infection by authentic and pseudotyped MERS-CoV","volume":"10","author":"Fan","year":"2018","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.micres.2022.126993_bib19","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0966-842X(96)10076-7","article-title":"Leukemogenesis by Moloney murine leukemia virus: a multistep process","volume":"5","author":"Fan","year":"1997","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.micres.2022.126993_bib20","first-page":"309","article-title":"The human Transmembrane Protease Serine 2 is necessary for the production of Group 2 influenza A virus pseudotypes","author":"Ferrara","year":"2012","journal-title":"J. Mol. Genet. Med."},{"issue":"6","key":"10.1016\/j.micres.2022.126993_bib21","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1093\/infdis\/jiab368","article-title":"SARS-CoV-2 B.1.617 mutations L452R and E484Q are not synergistic for antibody evasion","volume":"224","author":"Ferreira","year":"2021","journal-title":"J. Infect. Dis."},{"issue":"3","key":"10.1016\/j.micres.2022.126993_bib22","doi-asserted-by":"crossref","first-page":"95","DOI":"10.15585\/mmwr.mm7003e2","article-title":"Emergence of SARS-CoV-2 B.1.1.7 Lineage - United States, December 29, 2020-January 12, 2021","volume":"70","author":"Galloway","year":"2021","journal-title":"Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.micres.2022.126993_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.04.006","article-title":"Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity","author":"Garcia-Beltran","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.micres.2022.126993_bib24","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1743-422X-6-39","article-title":"Analysis of hemagglutinin-mediated entry tropism of H5N1 avian influenza","volume":"6","author":"Guo","year":"2009","journal-title":"Virol. J."},{"issue":"1","key":"10.1016\/j.micres.2022.126993_bib25","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.virol.2004.05.017","article-title":"Development of a safe neutralization assay for SARS-CoV and characterization of S-glycoprotein","volume":"326","author":"Han","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.micres.2022.126993_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.689065","article-title":"Generation and effect testing of a SARS-CoV-2 RBD-targeted polyclonal therapeutic antibody based on a 2-D airway organoid screening system","volume":"12","author":"He","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.micres.2022.126993_bib27","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.molcel.2020.04.022","article-title":"A multibasic cleavage site in the spike protein of SARS-CoV-2 is essential for infection of human lung cells","volume":"78","author":"Hoffmann","year":"2020","journal-title":"Mol. Cell"},{"issue":"2","key":"10.1016\/j.micres.2022.126993_bib28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.micres.2022.126993_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.03.036","article-title":"SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies","author":"Hoffmann","year":"2021","journal-title":"Cell"},{"issue":"6523","key":"10.1016\/j.micres.2022.126993_bib30","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1126\/science.abe8499","article-title":"SARS-CoV-2 D614G variant exhibits efficient replication ex vivo and transmission in vivo","volume":"370","author":"Hou","year":"2020","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.micres.2022.126993_bib31","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/s41423-021-00648-1","article-title":"Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies","volume":"18","author":"Hu","year":"2021","journal-title":"Cell. Mol. Immunol."},{"issue":"5485","key":"10.1016\/j.micres.2022.126993_bib32","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/252743a0","article-title":"Pseudotype formation between enveloped RNA and DNA viruses","volume":"252","author":"Huang","year":"1974","journal-title":"Nature"},{"key":"10.1016\/j.micres.2022.126993_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-021-03237-4","article-title":"Loss of furin cleavage site attenuates SARS-CoV-2 pathogenesis","author":"Johnson","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.micres.2022.126993_bib34","doi-asserted-by":"crossref","DOI":"10.2174\/18734316MTE35MjMbw","article-title":"The use of pseudotyped coronaviruses for the screening of entry inhibitors: green tea extract inhibits the entry of SARS-CoV-1, MERS-CoV, and SARS-CoV-2 by blocking receptor-spike interaction","author":"Joseph","year":"2021","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.micres.2022.126993_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2380-z","article-title":"Human neutralizing antibodies elicited by SARS-CoV-2 infection","author":"Ju","year":"2020","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.micres.2022.126993_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009439","article-title":"A novel cell culture system modeling the SARS-CoV-2 life cycle","volume":"17","author":"Ju","year":"2021","journal-title":"PLoS Pathog."},{"issue":"5","key":"10.1016\/j.micres.2022.126993_bib37","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1089\/hum.2006.194","article-title":"Human immunodeficiency viral vector pseudotyped with the spike envelope of severe acute respiratory syndrome coronavirus transduces human airway epithelial cells and dendritic cells","volume":"18","author":"Kobinger","year":"2007","journal-title":"Hum. Gene Ther."},{"issue":"4","key":"10.1016\/j.micres.2022.126993_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.06.043","article-title":"Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus","volume":"182","author":"Korber","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.micres.2022.126993_bib39","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12041000","article-title":"Envelope pseudotyped human immunodeficiency virus type-1 as a novel tool for glioblastoma-directed virotherapy","volume":"12","author":"Kretschmer","year":"2020","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.micres.2022.126993_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2021.03.008","article-title":"SARS-CoV-2 spike variants exhibit differential infectivity and neutralization resistance to convalescent or post-vaccination sera","volume":"29","author":"Kuzmina","year":"2021","journal-title":"Cell Host Microbe"},{"issue":"1","key":"10.1016\/j.micres.2022.126993_bib41","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1038\/s41467-020-16048-4","article-title":"Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig","volume":"11","author":"Lei","year":"2020","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.micres.2022.126993_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/rmv.1963","article-title":"Current status on the development of pseudoviruses for enveloped viruses","volume":"28","author":"Li","year":"2018","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.micres.2022.126993_bib43","article-title":"The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity","author":"Li","year":"2020","journal-title":"Cell"},{"issue":"13","key":"10.1016\/j.micres.2022.126993_bib44","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa2001316","article-title":"Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia","volume":"382","author":"Li","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"16","key":"10.1016\/j.micres.2022.126993_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.06.020","article-title":"Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum","volume":"184","author":"Liu","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.micres.2022.126993_bib46","doi-asserted-by":"crossref","first-page":"45552","DOI":"10.1038\/srep45552","article-title":"Antibody-dependent-cellular-cytotoxicity-inducing antibodies significantly affect the post-exposure treatment of Ebola virus infection","volume":"7","author":"Liu","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.micres.2022.126993_bib47","doi-asserted-by":"crossref","first-page":"5913","DOI":"10.1128\/JVI.78.11.5913-5922.2004","article-title":"Intracellular targeting signals contribute to localization of coronavirus spike proteins near the virus assembly site","volume":"78","author":"Lontok","year":"2004","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.micres.2022.126993_bib48","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/s13238-013-2125-y","article-title":"Pseudovirus-based neuraminidase inhibition assays reveal potential H5N1 drug-resistant mutations","volume":"4","author":"Lu","year":"2013","journal-title":"Protein Cell"},{"key":"10.1016\/j.micres.2022.126993_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2020.11.015","article-title":"Nanoparticle vaccines based on the receptor binding domain (RBD) and heptad repeat (HR) of SARS-CoV-2 elicit robust protective immune responses","author":"Ma","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.micres.2022.126993_bib50","article-title":"Properties of coronavirus and SARS-CoV-2","author":"Malik","year":"2020","journal-title":"Malays. J. Pathol."},{"issue":"1","key":"10.1016\/j.micres.2022.126993_bib51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1566523023348165","article-title":"Lentiviral vectors for gene therapy of HIV-1 infection","volume":"2","author":"Mautino","year":"2002","journal-title":"Curr. Gene Ther."},{"issue":"5","key":"10.1016\/j.micres.2022.126993_bib52","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1128\/JVI.02146-06","article-title":"The cytoplasmic tail of the severe acute respiratory syndrome coronavirus spike protein contains a novel endoplasmic reticulum retrieval signal that binds COPI and promotes interaction with membrane protein","volume":"81","author":"McBride","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.micres.2022.126993_bib53","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2607-z","article-title":"Single-shot Ad26 vaccine protects against SARS-CoV-2 in rhesus macaques","author":"Mercado","year":"2020","journal-title":"Nature"},{"issue":"42","key":"10.1016\/j.micres.2022.126993_bib54","doi-asserted-by":"crossref","first-page":"15214","DOI":"10.1073\/pnas.1407087111","article-title":"Host cell entry of Middle East respiratory syndrome coronavirus after two-step, furin-mediated activation of the spike protein","volume":"111","author":"Millet","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"23","key":"10.1016\/j.micres.2022.126993_bib55","article-title":"Murine leukemia virus (MLV)-based coronavirus spike-pseudotyped particle production and infection","volume":"6","author":"Millet","year":"2016","journal-title":"Bio Protoc."},{"issue":"7883","key":"10.1016\/j.micres.2022.126993_bib56","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/s41586-021-03944-y","article-title":"SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion","volume":"599","author":"Mlcochova","year":"2021","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.micres.2022.126993_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2021.06.006","article-title":"SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity","volume":"29","author":"Motozono","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micres.2022.126993_bib58","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2639-4","article-title":"Phase 1\/2 study of COVID-19 RNA vaccine BNT162b1 in adults","author":"Mulligan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.micres.2022.126993_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41596-020-0394-5","article-title":"Quantification of SARS-CoV-2 neutralizing antibody by a pseudotyped virus-based assay","author":"Nie","year":"2020","journal-title":"Nat. Protoc."},{"issue":"1","key":"10.1016\/j.micres.2022.126993_bib60","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1080\/22221751.2020.1743767","article-title":"Establishment and validation of a pseudovirus neutralization assay for SARS-CoV-2","volume":"9","author":"Nie","year":"2020","journal-title":"Emerg. Microbes Infect."},{"issue":"1","key":"10.1016\/j.micres.2022.126993_bib61","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1007\/s12250-020-00237-y","article-title":"Monitoring neutralization property change of evolving Hantaan and Seoul viruses with a novel pseudovirus-based assay","volume":"36","author":"Ning","year":"2021","journal-title":"Virol. Sin."},{"key":"10.1016\/j.micres.2022.126993_bib62","unstructured":"Organization WH. WHO Coronavirus (COVID-19) Dashboard 2021. WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data."},{"issue":"1","key":"10.1016\/j.micres.2022.126993_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009212","article-title":"Hydroxychloroquine-mediated inhibition of SARS-CoV-2 entry is attenuated by TMPRSS2","volume":"17","author":"Ou","year":"2021","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.micres.2022.126993_bib64","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","article-title":"Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV","volume":"11","author":"Ou","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.micres.2022.126993_bib65","article-title":"Development of an inactivated vaccine candidate for SARS-CoV-2","author":"Qiang Gao1*","year":"2020","journal-title":"Science"},{"issue":"19","key":"10.1016\/j.micres.2022.126993_bib66","doi-asserted-by":"crossref","first-page":"10176","DOI":"10.1128\/JVI.00422-09","article-title":"Rho GTPases modulate entry of Ebola virus and vesicular stomatitis virus pseudotyped vectors","volume":"83","author":"Quinn","year":"2009","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.micres.2022.126993_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001091","article-title":"A plasmid DNA-launched SARS-CoV-2 reverse genetics system and coronavirus toolkit for COVID-19 research","volume":"19","author":"Rihn","year":"2021","journal-title":"PLoS Biol."},{"key":"10.1016\/j.micres.2022.126993_bib68","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-1702(02)00026-6","article-title":"Emergence and re-emergence of vesicular stomatitis in the United States","author":"Rodr\u0131\u00b4guez","year":"2002","journal-title":"Virus Res."},{"key":"10.1016\/j.micres.2022.126993_bib69","article-title":"SARS-CoV-2 B.1.1.529 variant (Omicron) evades neutralization by sera from vaccinated and convalescent individuals","author":"Roessler","year":"2021","journal-title":"medRxiv"},{"issue":"22","key":"10.1016\/j.micres.2022.126993_bib70","doi-asserted-by":"crossref","first-page":"10321","DOI":"10.1128\/JVI.01714-16","article-title":"Characterization of vesicular stomatitis virus pseudotypes bearing essential entry glycoproteins gB, gD, gH, and gL of herpes simplex virus 1","volume":"90","author":"Rogalin","year":"2016","journal-title":"J. Virol."},{"key":"10.1016\/j.micres.2022.126993_bib71","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/978-1-4939-6869-5_12","article-title":"Generating recombinant vesicular stomatitis viruses for use as vaccine platforms","volume":"1581","author":"Ruedas","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.micres.2022.126993_bib72","article-title":"Pseudotyped vesicular stomatitis virus-severe acute respiratory syndrome-coronavirus-2 spike for the study of variants, vaccines, and therapeutics against coronavirus disease 2019","volume":"12","author":"Salazar-Garc\u00eda","year":"2021","journal-title":"Front. Microbiol."},{"issue":"7845","key":"10.1016\/j.micres.2022.126993_bib73","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/s41586-020-3035-9","article-title":"A single-dose live-attenuated YF17D-vectored SARS-CoV-2 vaccine candidate","volume":"590","author":"Sanchez-Felipe","year":"2021","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.micres.2022.126993_bib74","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201181","article-title":"Measuring SARS-CoV-2 neutralizing antibody activity using pseudotyped and chimeric viruses","volume":"217","author":"Schmidt","year":"2020","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.micres.2022.126993_bib75","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1073\/pnas.0306446101","article-title":"Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry","volume":"101","author":"Simmons","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"4","key":"10.1016\/j.micres.2022.126993_bib76","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1093\/nar\/23.4.628","article-title":"A transient three-plasmid expression system for the production of high titer retroviral vectors","volume":"23","author":"Soneoka","year":"1995","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.micres.2022.126993_bib77","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.virol.2006.11.027","article-title":"The intracellular sites of early replication and budding of SARS-coronavirus","volume":"361","author":"Stertz","year":"2007","journal-title":"Virology"},{"issue":"5","key":"10.1016\/j.micres.2022.126993_bib78","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.micres.2012.12.004","article-title":"CD4 detected from Lactobacillus helps understand the interaction between Lactobacillus and HIV","volume":"168","author":"Su","year":"2013","journal-title":"Microbiol. Res."},{"issue":"26","key":"10.1016\/j.micres.2022.126993_bib79","doi-asserted-by":"crossref","first-page":"14764","DOI":"10.1073\/pnas.94.26.14764","article-title":"A system for functional analysis of Ebola virus glycoprotein","volume":"94","author":"Takada","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1\u20132","key":"10.1016\/j.micres.2022.126993_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jviromet.2009.02.025","article-title":"Development of a neutralization assay for Nipah virus using pseudotype particles","volume":"160","author":"Tamin","year":"2009","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.micres.2022.126993_bib81","first-page":"272","article-title":"Development and applications of VSV vectors based on cell tropism","volume":"2","author":"Tani","year":"2011","journal-title":"Front. Microbiol."},{"issue":"6","key":"10.1016\/j.micres.2022.126993_bib82","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.1128\/JVI.02499-09","article-title":"Involvement of ceramide in the propagation of Japanese encephalitis virus","volume":"84","author":"Tani","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.micres.2022.126993_bib83","article-title":"Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa","author":"Tegally","year":"2020","journal-title":"MedRxiv"},{"issue":"1","key":"10.1016\/j.micres.2022.126993_bib84","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41467-020-20653-8","article-title":"SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice","volume":"12","author":"Tian","year":"2021","journal-title":"Nat. Commun."},{"issue":"8","key":"10.1016\/j.micres.2022.126993_bib85","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1099\/jgv.0.000494","article-title":"The contribution of the cytoplasmic retrieval signal of severe acute respiratory syndrome coronavirus to intracellular accumulation of S proteins and incorporation of S protein into virus-like particles","volume":"97","author":"Ujike","year":"2016","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.micres.2022.126993_bib86","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2608-y","article-title":"ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques","author":"van Doremalen","year":"2020","journal-title":"Nature"},{"issue":"7853","key":"10.1016\/j.micres.2022.126993_bib87","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41586-021-03275-y","article-title":"BNT162b vaccines protect rhesus macaques from SARS-CoV-2","volume":"592","author":"Vogel","year":"2021","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.micres.2022.126993_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/0092-8674(85)90303-4","article-title":"Nucleotide sequence of the AIDS virus, LAV","volume":"40","author":"Wain-Hobson","year":"1985","journal-title":"Cell"},{"issue":"2","key":"10.1016\/j.micres.2022.126993_bib89","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.micres.2022.126993_bib90","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nsmb.3293","article-title":"Glycan shield and epitope masking of a coronavirus spike protein observed by cryo-electron microscopy","volume":"23","author":"Walls","year":"2016","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"3","key":"10.1016\/j.micres.2022.126993_bib91","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.cell.2020.06.008","article-title":"Development of an inactivated vaccine candidate, BBIBP-CorV, with potent protection against SARS-CoV-2","volume":"182","author":"Wang","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.micres.2022.126993_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.chom.2021.04.007","article-title":"Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization","volume":"29","author":"Wang","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micres.2022.126993_bib93","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7","author":"Wang","year":"2021","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.micres.2022.126993_bib94","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.chom.2014.08.009","article-title":"Bat origins of MERS-CoV supported by bat coronavirus HKU4 usage of human receptor CD26","volume":"16","author":"Wang","year":"2014","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micres.2022.126993_bib95","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1742-4690-10-14","article-title":"A systematic study of the N-glycosylation sites of HIV-1 envelope protein on infectivity and antibody-mediated neutralization","volume":"10","author":"Wang","year":"2013","journal-title":"Retrovirology"},{"issue":"2","key":"10.1016\/j.micres.2022.126993_bib96","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jviromet.2008.07.015","article-title":"Establishment of retroviral pseudotypes with influenza hemagglutinins from H1, H3, and H5 subtypes for sensitive and specific detection of neutralizing antibodies","volume":"153","author":"Wang","year":"2008","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.micres.2022.126993_bib97","article-title":"mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.micres.2022.126993_bib98","doi-asserted-by":"crossref","DOI":"10.1038\/s42255-020-00324-0","article-title":"HDL-scavenger receptor B type 1 facilitates SARS-CoV-2 entry","author":"Wei","year":"2020","journal-title":"Nat. Metab."},{"issue":"2","key":"10.1016\/j.micres.2022.126993_bib99","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.jviromet.2010.08.006","article-title":"Generation of VSV pseudotypes using recombinant \u0394G-VSV for studies on virus entry, identification of entry inhibitors, and immune responses to vaccines","volume":"169","author":"Whitt","year":"2010","journal-title":"J. Virol. Methods"},{"issue":"3","key":"10.1016\/j.micres.2022.126993_bib100","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/0092-8674(77)90068-X","article-title":"Mechanism of formation of pseudotypes between vesicular stomatitis virus and murine leukemia virus","volume":"11","author":"Witte","year":"1977","journal-title":"Cell"},{"issue":"Pt 9","key":"10.1016\/j.micres.2022.126993_bib101","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1099\/vir.0.2008\/000349-0","article-title":"Investigating antibody neutralization of lyssaviruses using lentiviral pseudotypes: a cross-species comparison","volume":"89","author":"Wright","year":"2008","journal-title":"J. Gen. Virol."},{"issue":"7798","key":"10.1016\/j.micres.2022.126993_bib102","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"issue":"47","key":"10.1016\/j.micres.2022.126993_bib103","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1016\/j.vaccine.2017.10.007","article-title":"Development and application of a bioluminescent imaging mouse model for Chikungunya virus based on pseudovirus system","volume":"35","author":"Wu","year":"2017","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.micres.2022.126993_bib104","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.chom.2020.04.004","article-title":"An Infectious cDNA Clone of SARS-CoV-2","volume":"27","author":"Xie","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.micres.2022.126993_bib105","article-title":"A high throughput screening assay for inhibitors of SARS-CoV-2 pseudotyped particle entry","author":"Xu","year":"2021","journal-title":"bioRxiv: Prepr. Serv. Biol."},{"key":"10.1016\/j.micres.2022.126993_bib106","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2599-8","article-title":"A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity","author":"Yang","year":"2020","journal-title":"Nature"},{"issue":"8","key":"10.1016\/j.micres.2022.126993_bib107","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1038\/s41401-020-00556-6","article-title":"Identification of SARS-CoV-2 entry inhibitors among already approved drugs","volume":"42","author":"Yang","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.micres.2022.126993_bib108","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.61552","article-title":"Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration","volume":"9","author":"Yang","year":"2020","journal-title":"eLife"},{"issue":"3","key":"10.1016\/j.micres.2022.126993_bib109","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/j.cell.2020.09.018","article-title":"Molecular architecture of the SARS-CoV-2 virus","volume":"183","author":"Yao","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.micres.2022.126993_bib110","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00044-21","article-title":"Deletion of the SARS-CoV-2 spike cytoplasmic tail increases infectivity in pseudovirus neutralization assays","author":"Yu","year":"2021","journal-title":"J. Virol."},{"key":"10.1016\/j.micres.2022.126993_bib111","article-title":"The significant immune escape of pseudotyped SARS-CoV-2 Variant Omicron","author":"Zhang","year":"2021","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.micres.2022.126993_bib112","article-title":"A thermostable mRNA vaccine against COVID-19","author":"Zhang","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.micres.2022.126993_bib113","article-title":"A trans-complementation system for SARS-CoV-2 recapitulates authentic viral replication without virulence","author":"Zhang","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.micres.2022.126993_bib114","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1186\/1743-422X-10-266","article-title":"A safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoV","volume":"10","author":"Zhao","year":"2013","journal-title":"Virol. J."},{"key":"10.1016\/j.micres.2022.126993_bib115","first-page":"82","article-title":"Effect of the maturation of neutralizing antibodies on human immunodeficiency virus (HIV) envelope evolution in HIV-infected subjects","volume":"38","author":"Zhao","year":"2016","journal-title":"Infect. Genet. Evol. J. Mol. Epidemiol. Evolut. Genet. Infect. Dis."},{"issue":"1","key":"10.1016\/j.micres.2022.126993_bib116","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12985-020-01472-1","article-title":"Neutralization assay with SARS-CoV-1 and SARS-CoV-2 spike pseudotyped murine leukemia virions","volume":"18","author":"Zheng","year":"2021","journal-title":"Virol. J."},{"issue":"7798","key":"10.1016\/j.micres.2022.126993_bib117","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.micres.2022.126993_bib118","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1016\/j.vaccine.2016.04.029","article-title":"A safe and sensitive enterovirus A71 infection model based on human SCARB2 knock-in mice","volume":"34","author":"Zhou","year":"2016","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.micres.2022.126993_bib119","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00635-20","article-title":"Design of potent membrane fusion inhibitors against SARS-CoV-2, an emerging coronavirus with high fusogenic activity","volume":"94","author":"Zhu","year":"2020","journal-title":"J. Virol."}],"container-title":["Microbiological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944501322000337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0944501322000337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:57:02Z","timestamp":1760551022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0944501322000337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":119,"alternative-id":["S0944501322000337"],"URL":"https:\/\/doi.org\/10.1016\/j.micres.2022.126993","relation":{},"ISSN":["0944-5013"],"issn-type":[{"value":"0944-5013","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of pseudovirus system in the development of vaccine, antiviral-drugs, and neutralizing antibodies","name":"articletitle","label":"Article Title"},{"value":"Microbiological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micres.2022.126993","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"126993"}}